"Designing Growth Strategies is in our DNA"

Chronic Disease Management Market Size, Share & Industry Analysis, By Type (Software and Services), By Disease Indication (Cardiovascular Diseases, Diabetes, Chronic Respiratory Diseases, Cancer, and Others), By Deployment Type (Cloud-based, On-Premise, and Hybrid), By Service Provider (Hospitals & Health Systems, Physician Practices & Specialty Clinics, Home Healthcare & Community-Based Care Providers, and Others), and Regional Forecast, 2026-2034

Last Updated: October 01, 2026 | Format: PDF | Report ID: FBI119294

 


To get information on various segments, share your queries with us

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year 2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 12.3% from 2026-2034
Unit Value (USD Billion)
Segmentation By Type, Disease Indication, Deployment Type, Service Provider, and Region
By Type
  • Software
  • Services
By Disease Indication
  • Cardiovascular Diseases
  • Diabetes
  • Chronic Respiratory Diseases
  • Cancer
  • Others
By Deployment Type
  • Cloud-Based
  • On-Premise
  • Hybrid
By Service Provider
  • Hospitals & Health Systems
  • Physician Practices & Specialty Clinics
  • Home Healthcare & Community-Based Care Providers
  • Others
By Region
  • North America (By Type, By Disease Indication, By Deployment Type, By Service Provider, and by Country)
    • U.S. (By Type)
    • Canada (By Type)
  • Europe (By Type, By Disease Indication, By Deployment Type, By Service Provider, and by Country/Sub-region)
    • U.K. (By Type)
    • Germany (By Type)
    • France (By Type)
    • Italy (By Type)
    • Spain (By Type)
    • Scandinavia (By Type)
    • Rest of Europe (By Type) 
  • Asia Pacific (By Type, By Disease Indication, By Deployment Type, By Service Provider, and by Country/Sub-region)
    • China (By Type)
    • Japan (By Type)
    • India (By Type)
    • Australia (By Type)
    • Southeast Asia (By Type)
    • Rest of Asia Pacific (By Type)
  • Latin America (By Type, By Disease Indication, By Deployment Type, By Service Provider, and by Country/Sub-region)
    • Brazil (By Type)
    • Mexico (By Type)
    • Rest of Latin America (By Type)
  • Middle East & Africa (By Type, By Disease Indication, By Deployment Type, By Service Provider, and by Country/Sub-region)
    • GCC (By Type)
    • South Africa (By Type)
    • Rest of Middle East & Africa (By Type)

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 261
Download Free Sample

    man icon
    Mail icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann